🇺🇸 FDA
Patent

US 10543268

Genetically engineered swine influenza virus and uses thereof

granted A61KA61K2039/5254A61K2039/5256

Quick answer

US patent 10543268 (Genetically engineered swine influenza virus and uses thereof) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of Agriculture
Grant date
Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K2039/5254, A61K2039/5256, A61K2039/544, A61K2039/552